Header Logo

Connection

SUSAN BLANEY to Animals

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Animals.
SUSAN BLANEY
Connection Strength
0.362
Animals
  1. Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemother Pharmacol. 2011 Apr; 67(4):809-12.
    View in: PubMed
    Score: 0.020
  2. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates. Cancer Chemother Pharmacol. 2008 Apr; 61(4):647-52.
    View in: PubMed
    Score: 0.016
  3. Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates. Cancer Chemother Pharmacol. 2007 May; 59(6):743-7.
    View in: PubMed
    Score: 0.015
  4. New agents for intrathecal administration. Cancer Invest. 2006 Aug-Sep; 24(5):528-34.
    View in: PubMed
    Score: 0.015
  5. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates. Cancer Chemother Pharmacol. 2007 Mar; 59(4):461-6.
    View in: PubMed
    Score: 0.015
  6. Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates. Clin Cancer Res. 2005 Aug 15; 11(16):5981-3.
    View in: PubMed
    Score: 0.014
  7. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
    View in: PubMed
    Score: 0.014
  8. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Aug; 54(2):127-30.
    View in: PubMed
    Score: 0.013
  9. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clin Cancer Res. 2004 Apr 01; 10(7):2525-9.
    View in: PubMed
    Score: 0.013
  10. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jul; 54(1):85-8.
    View in: PubMed
    Score: 0.013
  11. Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jun; 53(6):527-32.
    View in: PubMed
    Score: 0.013
  12. Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jan; 53(1):39-42.
    View in: PubMed
    Score: 0.013
  13. Incorporation of an enrichment program into a study protocol involving long-term restraint in macaques. Lab Anim (NY). 2002 Nov; 31(10):37-9.
    View in: PubMed
    Score: 0.012
  14. Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate. Cancer Chemother Pharmacol. 2001 May; 47(5):385-90.
    View in: PubMed
    Score: 0.011
  15. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2001 May; 47(5):411-4.
    View in: PubMed
    Score: 0.011
  16. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. Cancer Discov. 2021 09; 11(9):2200-2215.
    View in: PubMed
    Score: 0.011
  17. Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother. 2000 Oct; 34(10):1173-8.
    View in: PubMed
    Score: 0.010
  18. Modified procedure for implantation of subcutaneous central venous access devices in macaques (Macaca mulatta). Comp Med. 2000 Oct; 50(5):486-9.
    View in: PubMed
    Score: 0.010
  19. A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019 06 01; 25(11):3229-3238.
    View in: PubMed
    Score: 0.009
  20. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol. 1999; 43(5):415-8.
    View in: PubMed
    Score: 0.009
  21. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates. Cancer Chemother Pharmacol. 1998; 41(6):464-8.
    View in: PubMed
    Score: 0.008
  22. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates. Antimicrob Agents Chemother. 1995 Dec; 39(12):2779-82.
    View in: PubMed
    Score: 0.007
  23. Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4.
    View in: PubMed
    Score: 0.007
  24. Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9.
    View in: PubMed
    Score: 0.007
  25. Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. Neuro Oncol. 2013 Sep; 15(9):1173-85.
    View in: PubMed
    Score: 0.006
  26. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993 Feb 15; 53(4):725-7.
    View in: PubMed
    Score: 0.006
  27. Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012 Aug; 7(8):1133-48.
    View in: PubMed
    Score: 0.006
  28. Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9.
    View in: PubMed
    Score: 0.005
  29. Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol. 2011 Aug; 104(1):55-63.
    View in: PubMed
    Score: 0.005
  30. A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol. 2011 Jan; 13(1):14-27.
    View in: PubMed
    Score: 0.005
  31. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010 Jun; 12(6):580-94.
    View in: PubMed
    Score: 0.005
  32. Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates. Cancer Chemother Pharmacol. 2010 Feb; 65(3):419-25.
    View in: PubMed
    Score: 0.005
  33. Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates. Cancer Chemother Pharmacol. 2009 Jul; 64(2):335-40.
    View in: PubMed
    Score: 0.004
  34. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells. 2008 Jun; 26(6):1414-24.
    View in: PubMed
    Score: 0.004
  35. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts. Clin Cancer Res. 2006 Aug 01; 12(15):4687-94.
    View in: PubMed
    Score: 0.004
  36. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther. 2005 Dec; 4(12):1912-22.
    View in: PubMed
    Score: 0.004
  37. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Clin Cancer Res. 2004 Feb 01; 10(3):1150-9.
    View in: PubMed
    Score: 0.003
  38. Testing of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res. 2002 Dec; 8(12):3646-57.
    View in: PubMed
    Score: 0.003
  39. Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Clin Cancer Res. 2002 Jul; 8(7):2437-42.
    View in: PubMed
    Score: 0.003
  40. Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate. Clin Cancer Res. 2000 Mar; 6(3):994-7.
    View in: PubMed
    Score: 0.002
  41. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.
    View in: PubMed
    Score: 0.002
  42. A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Cancer Res. 1994 Oct 01; 54(19):5118-22.
    View in: PubMed
    Score: 0.002
  43. Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.